US health regulator approves Teva's migraine drug
Israeli drugmaker Teva Pharmaceutical Industries on Friday received approval from the U.S. Food and Drug Administration to sell its new migraine treatment, a key drug the company has been banking on to help revive its fortunes. A man walks past the logo of Teva Pharmaceutical Industries at their plant in Jerusalem December 14, 2017.
from Biotech News
0 Comments